Looking at long term trends. Old breakout finished with multi year consolidation. New breakout started with all time high. Will this new breakout hold?
Trade active:
With the most recent news that trump used regn-cov2, the recent downward pressure will likely end. More trial data before year end. Maybe an emergency use authorization.
q3 earnings and eoy cancer update
Ebola virus infection and is currently under Priority Review by the U.S. Food and Drug Administration (FDA), with a target action date of October 25, 2020.
q3 earnings and eoy cancer update
Ebola virus infection and is currently under Priority Review by the U.S. Food and Drug Administration (FDA), with a target action date of October 25, 2020.